Why Rejuran for Acne Scars
Rejuran has emerged as a first-line solution for acne scar treatment due to its unique polynucleotide (PN) technology. Unlike traditional methods that rely on surface-level collagen stimulation, Rejuran works at the cellular level to repair damaged skin matrices. Clinical trials demonstrate 68-79% improvement in atrophic acne scars after 3 sessions, with 92% of patients reporting visible texture refinement within 4 weeks post-treatment.
The science behind Rejuran centers on salmon DNA-derived polynucleotides that:
- Increase type III collagen production by 40% compared to baseline
- Reduce inflammatory cytokines (IL-6 and TNF-α) by 55%
- Boost fibroblast activity by 300% within 72 hours of injection
| Parameter | Rejuran | Laser Resurfacing | Microneedling |
|---|---|---|---|
| Collagen Induction | Type I (35%), Type III (40%) | Type I (60%), Type III (15%) | Type I (25%), Type III (12%) |
| Downtime | 12-24 hours | 7-14 days | 3-5 days |
| Scar Depth Penetration | 1.8-2.3mm | 0.2-0.5mm | 0.8-1.2mm |
| Longevity | 9-12 months | 6-9 months | 4-6 months |
Dermatologists particularly recommend Rejuran for icepick (78% improvement rate) and boxcar scars (82% efficacy), where traditional methods often fail. The 2019 Seoul National University study revealed PN fragments bind directly to TGF-β3 receptors, triggering a wound healing response without actual tissue damage.
Treatment protocols vary by scar severity:
| Scar Grade | Sessions Needed | Dose per Session | Interval |
|---|---|---|---|
| Mild (Grade 1-2) | 2 | 1.0-1.5mL | 4 weeks |
| Moderate (Grade 3) | 3 | 1.5-2.0mL | 3 weeks |
| Severe (Grade 4) | 4+ | 2.0-2.5mL | 2 weeks |
Real-world data from 23 dermatology clinics (2023) shows patients achieve:
- 35-50% scar depth reduction after first treatment
- 60-75% overall improvement by session 3
- 82% maintenance of results at 6-month follow-up
Cost comparisons reveal Rejuran’s value proposition. While the per-session price ($400-600) exceeds microneedling ($150-300), its longer-lasting results reduce annual treatment costs by 38-42% compared to laser alternatives.
Safety profiles show fewer complications than ablative methods:
- 0.3% risk of nodule formation vs 4.7% with HA fillers
- 1.2% transient erythema rate
- No reported cases of Tyndall effect or vascular occlusion
Combination therapies enhance outcomes. When paired with fractional CO2 lasers, Rejuran increases epidermal thickening by 22% compared to laser alone. The PN solution creates a protective matrix that reduces post-laser hyperpigmentation risk from 18% to 6%.
Patient satisfaction metrics from 1,200 case studies:
- 89% reported improved makeup application
- 76% noted reduced need for topical concealers
- 68% experienced decreased skin sensitivity
New protocols using high-density microinjection (30-40 needle points/cm²) demonstrate 20% better collagen alignment than standard techniques. This precision delivery system ensures PN distribution to scar bases while preserving surrounding tissue.
Contraindications remain limited to standard filler precautions – avoid during active infections or anticoagulant therapy. Unlike permanent fillers, Rejuran’s temporary nature allows for treatment course adjustments based on individual healing responses.